EVAN GERONDALE: Open Payments
NPI 1336730662 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 53 payments from 12 companies in 2025. Trend: 2023 $1,619 · 2024 $1,517 · 2025 $1,414
Food & beverage: $1,414
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $404 |
| UCB, Inc. | 6 | $208 |
| Incyte Corporation | 6 | $155 |
| Arcutis Biotherapeutics, Inc. | 4 | $144 |
| Janssen Biotech, Inc. | 2 | $141 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| Organon LLC | 6 | $86 |
| E.R. Squibb & Sons, L.L.C. | 2 | $78 |
| GENZYME CORPORATION | 1 | $35 |
| Organogenesis Inc. | 2 | $35 |
Products named: RINVOQ, Bimzelx, SKYRIZI, OPZELURA, Zoryve, TREMFYA, DUPIXENT, Sotyktu.
Industry payments across MI — which companies pay providers there.
